FDA Officially Ranks Condoms for Anal and Vaginal Use as 'Class II' Gadgets
Published Date: 5/8/2026
Rule
Summary
The FDA is officially classifying external condoms for anal or vaginal sex as Class II devices, meaning they have special safety rules but aren’t super strict. This change helps make sure condoms are safe and effective while making it easier for new, innovative products to reach you. The new rules took effect on May 8, 2026, and could speed up how quickly better condoms hit the market without extra costs.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Condoms Reclassified to Class II
The FDA has officially classified external condoms for anal or vaginal intercourse as Class II (special controls). FDA says this classification provides a reasonable assurance of safety and effectiveness and will enhance patient access to innovative condom products by reducing regulatory burdens; the order is effective May 8, 2026 (classification applicable February 23, 2022).
New Testing and Labeling Rules for Makers
Manufacturers must meet new special controls: clinical acute failure modes studies for total and individual failure rates; non‑clinical performance testing including mechanical/material integrity and (for non‑latex materials) viral penetration testing; biocompatibility evaluation; shelf‑life performance and package integrity data; and specific labeling elements. These controls are codified at 21 CFR 884.5305 and apply to devices classified as external condoms for anal or vaginal intercourse.
Premarket 510(k) Notification Required
FDA states that external condoms for anal or vaginal intercourse are subject to premarket notification under section 510(k) of the FD&C Act and that it has not determined these devices should be exempt under section 510(m). Sponsors must therefore submit a 510(k) to market these devices unless FDA later exempts them.
Labels Must Give Clear Safety & Effectiveness Info
Required labeling must include (if indicated for vaginal intercourse) a contraceptive effectiveness table comparing typical and perfect use pregnancy rates; statements on lubricant compatibility; statements of adverse events (including infection, pregnancy, tissue reaction, mechanical injury, improper use); an expiration date; STI protection specifics; a statement that risks are not eliminated; a warning about failure during anal intercourse if adequate lubricant is not used; a warning that the device is single‑use; and a precaution about allergy risk.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in